Literature DB >> 16281999

The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study.

Peter M Brindle1, Alex McConnachie, Mark N Upton, Carole L Hart, George Davey Smith, Graham C M Watt.   

Abstract

BACKGROUND: The primary prevention of cardiovascular disease involves using the Framingham risk score to identify high risk patients and then prescribe preventive treatments. AIM: To examine the performance of the Framingham risk score in different socioeconomic groups in a population with high rates of cardiovascular disease. DESIGN OF STUDY: A prospective study.
SETTING: West of Scotland.
METHOD: The observed 10-year cardiovascular disease and coronary heart disease mortality rates in 5626 men and 6678 women free from cardiovascular disease from the Renfrew/Paisley Study were compared with predicted rates, stratified by socioeconomic class and by area deprivation score.
RESULTS: The ratio of predicted to observed cardiovascular mortality rate in the 12 304 men and women with complete risk factor information was 0.56 (95% confidence interval [CI] = 0.52 to 0.60), a relative underestimation of 44%. Cardiovascular disease mortality was underestimated by 48% in manual participants (predicted over observed = 0.52, 95% CI = 0.48 to 0.56) compared to 31% in the non-manual participants (predicted over observed = 0.69, 95% CI = 0.60 to 0.81, P = 0.0005). Underestimation was also worse in participants from deprived areas (P = 0.0017). Only 4.8% of individuals had a 10-year cardiovascular risk of >40% (equivalent to >30% 10-year coronary risk), and 81% of deaths occurred in the rest. If the Framingham score had been recalibrated for manual and non-manual members of this population, an additional 3611 individuals mainly from manual social classes would have reached the treatment threshold.
CONCLUSION: Currently recommended risk scoring methods underestimate risk in socioeconomically deprived individuals. The likely consequence is that preventive treatments are less available to the most needy.

Entities:  

Mesh:

Year:  2005        PMID: 16281999      PMCID: PMC1570792     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  22 in total

1.  Using the Framingham model to predict heart disease in the United Kingdom: retrospective study.

Authors:  S Ramachandran; J M French; M P Vanderpump; P Croft; R H Neary
Journal:  BMJ       Date:  2000-03-11

2.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors:  J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

3.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

4.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

5.  A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.

Authors:  S J Pocock; V McCormack; F Gueyffier; F Boutitie; R H Fagard; J P Boissel
Journal:  BMJ       Date:  2001-07-14

6.  Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts.

Authors:  Hans-Werner Hense; Helmut Schulte; Hannelore Löwel; Gerd Assmann; Ulrich Keil
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

7.  A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.

Authors:  Troels F Thomsen; Dan McGee; Michael Davidsen; Torben Jørgensen
Journal:  Int J Epidemiol       Date:  2002-08       Impact factor: 7.196

8.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

10.  Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?

Authors: 
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

View more
  56 in total

1.  The value of risk scores.

Authors:  J S Jürgensen
Journal:  Heart       Date:  2006-06-06       Impact factor: 5.994

2.  Cardiovascular risk estimation: important but may be inaccurate.

Authors:  Vishnu Madhok; Tom Fahey
Journal:  BMJ       Date:  2006-05-31

Review 3.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Authors:  P Brindle; A Beswick; T Fahey; S Ebrahim
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

4.  Deprived people less likely to get treatment to prevent heart disease.

Authors:  Stephen Willott
Journal:  Br J Gen Pract       Date:  2006-02       Impact factor: 5.386

5.  Diagnosing chest pain in general practice.

Authors:  Neil C Campbell
Journal:  BMJ       Date:  2006-03-18

6.  Can non-physician health-care workers assess and manage cardiovascular risk in primary care?

Authors:  Dele O Abegunde; Bakuti Shengelia; Anne Luyten; Alexandra Cameron; Francesca Celletti; Sania Nishtar; Vasu Pandurangi; Shanthi Mendis
Journal:  Bull World Health Organ       Date:  2007-06       Impact factor: 9.408

7.  Rationale for recommendations for lipid testing and reporting by Australian pathology laboratories.

Authors:  David R Sullivan; David W Thomas; David P Tognarini
Journal:  Clin Biochem Rev       Date:  2007-05

8.  Life course socioeconomic adversities and 10-year risk of cardiovascular disease: cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health.

Authors:  Dayse Rodrigues de Sousa Andrade; Lidyane V Camelo; Rodrigo Citton P Dos Reis; Itamar S Santos; Antonio Luiz Ribeiro; Luana Giatti; Sandhi Maria Barreto
Journal:  Int J Public Health       Date:  2016-12-02       Impact factor: 3.380

9.  Individual- and Area-Level SES in Diabetes Risk Prediction: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Paul J Christine; Rebekah Young; Sara D Adar; Alain G Bertoni; Michele Heisler; Mercedes R Carnethon; Rodney A Hayward; Ana V Diez Roux
Journal:  Am J Prev Med       Date:  2017-08       Impact factor: 5.043

10.  Subjective socioeconomic status predicts Framingham cardiovascular disease risk for whites, not blacks.

Authors:  Allyssa J Allen; Jessica M McNeely; Shari R Waldstein; Michele K Evans; Alan B Zonderman
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.